P. Sondermann

986 total citations · 1 hit paper
9 papers, 794 citations indexed

About

P. Sondermann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, P. Sondermann has authored 9 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Organic Chemistry. Recurrent topics in P. Sondermann's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (6 papers) and Chronic Lymphocytic Leukemia Research (2 papers). P. Sondermann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (6 papers) and Chronic Lymphocytic Leukemia Research (2 papers). P. Sondermann collaborates with scholars based in Germany, Italy and United Kingdom. P. Sondermann's co-authors include Roy Jefferis, S. Krapp, Yusuke Mimura, Robert Huber, Uwe Jacob, Vaughan Oosthuizen, Heribert Jürgens, Marc Hotfilder, Josef Vormoor and F. van Valen and has published in prestigious journals such as The EMBO Journal, Journal of Molecular Biology and British Journal of Cancer.

In The Last Decade

P. Sondermann

8 papers receiving 760 citations

Hit Papers

Structural Analysis of Human IgG-Fc Glycoforms Reveals a ... 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sondermann Germany 8 620 608 321 43 40 9 794
Christiane Jäger Switzerland 3 468 0.8× 462 0.8× 311 1.0× 38 0.9× 32 0.8× 3 605
Radmila Moudry Switzerland 6 455 0.7× 534 0.9× 243 0.8× 80 1.9× 37 0.9× 10 701
Rosina Plomp Netherlands 16 768 1.2× 915 1.5× 626 2.0× 43 1.0× 36 0.9× 20 1.3k
R. Douglas United States 11 509 0.8× 464 0.8× 409 1.3× 24 0.6× 56 1.4× 14 857
Ling C. Santora United States 7 397 0.6× 366 0.6× 182 0.6× 121 2.8× 23 0.6× 10 576
Akito Natsume Japan 9 543 0.9× 442 0.7× 294 0.9× 142 3.3× 78 1.9× 9 684
William D. Bedzyk United States 13 328 0.5× 305 0.5× 246 0.8× 42 1.0× 27 0.7× 19 550
G. Seemann Germany 11 190 0.3× 299 0.5× 398 1.2× 135 3.1× 20 0.5× 18 786
Agnes L. Hipgrave Ederveen Netherlands 19 348 0.6× 721 1.2× 400 1.2× 41 1.0× 33 0.8× 33 1.0k
Peter R. Blier United States 10 337 0.5× 641 1.1× 361 1.1× 136 3.2× 35 0.9× 14 1.1k

Countries citing papers authored by P. Sondermann

Since Specialization
Citations

This map shows the geographic impact of P. Sondermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sondermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sondermann more than expected).

Fields of papers citing papers by P. Sondermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sondermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sondermann. The network helps show where P. Sondermann may publish in the future.

Co-authorship network of co-authors of P. Sondermann

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sondermann. A scholar is included among the top collaborators of P. Sondermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sondermann. P. Sondermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Werwitzke, Sonja, P. Sondermann, Kenji Kamino, et al.. (2007). Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32). Annals of the Rheumatic Diseases. 67(2). 154–161. 40 indexed citations
3.
Hotfilder, Marc, et al.. (2005). PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death. British Journal of Cancer. 92(4). 705–710. 33 indexed citations
4.
Krapp, S., Yusuke Mimura, Roy Jefferis, Robert Huber, & P. Sondermann. (2003). Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural Integrity. Journal of Molecular Biology. 325(5). 979–989. 530 indexed citations breakdown →
5.
Sondermann, P. & Vaughan Oosthuizen. (2002). X-ray crystallographic studies of IgG-Fcγ receptor interactions. Biochemical Society Transactions. 30(4). 481–486. 28 indexed citations
6.
Sondermann, P. & Vaughan Oosthuizen. (2002). X-ray crystallographic studies of IgG-FcγR interactions. Biochemical Society Transactions. 30(3). A65–A65. 1 indexed citations
7.
Sondermann, P. & Uwe Jacob. (1999). Human Fc gamma Receptor IIb Expressed in <I>Escherichia coli</I> Reveals IgG Binding Capability. Biological Chemistry. 380(6). 717–721. 30 indexed citations
9.
Sondermann, P., et al.. (1996). Epitope Mapping of New Monoclonal Antibodies Recognizing Distinct Human FcRII (CD32) Isoforms. Hybridoma. 15(2). 109–116. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026